Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20061
20072
20081
20095
20111
20121
20135
20141
20151
20182
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation6
AstraZeneca4
Novartis Pharmaceuticals3
Bayer2
Abbott Medical Devices1
Amarin Pharma Inc.1
Amgen1
Austin Health1
CSL Behring1
Cogentus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease27
Myocardial Infarction5
Acute Coronary Syndrome4
Cardiovascular Diseases4
Heart Diseases4
Myocardial Ischemia4
Stroke4
Atherosclerosis3
Diabetes Mellitus, Type 23
Peripheral Arterial Disease3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.